Quest Diagnostics (DGX) Change in Accured Expenses (2009 - 2026)

Quest Diagnostics has disclosed Change in Accured Expenses across 18 years of filings, most recently posting $142.0 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 238.1% year-over-year to $142.0 million; the TTM figure through Jun 2026 stood at $270.0 million (up 718.18% YoY), while the FY2025 annual figure was $129.0 million, up 292.54% from the prior year.
• Change in Accured Expenses came in at $142.0 million for Q2 2026 at Quest Diagnostics, up from -$12.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $176.0 million in Q4 2023 to a low of -$211.0 million in Q1 2023.
• Average Change in Accured Expenses over 5 years is -$666666.7, with a median of $18.0 million recorded in 2022.
• Year-over-year, Change in Accured Expenses jumped 2100.0% in 2022 and plunged 334.38% in 2023.
• Over 5 years, Change in Accured Expenses stood at $20.0 million in 2022, then surged by 780.0% to $176.0 million in 2023, then slumped by 80.11% to $35.0 million in 2024, then slumped by 54.29% to $16.0 million in 2025, then jumped by 787.5% to $142.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $142.0 million in Q2 2026, -$12.0 million in Q1 2026, and $16.0 million in Q4 2025.